Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable

Author： Rosa Fernanda  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.32, Iss.4, 2012-04, pp. : 267-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Acting Injectable Risperidone for the Treatment of Schizophrenia: Clinical Perspectives

By Möller Hans-Jürgen  

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1541-1566

Adis International

Access to resources Recommend Favorite

Switching from oral antipsychotics to long-acting risperidone

By  

Inpharma, Vol. 1, Iss. 1459, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Spotlight on Long-Acting Risperidone in Schizophrenia

By Tracy Swainston Harrison   Karen L. Goa  

American Journal of Drug Delivery, Vol. 2, Iss. 3, 2004-01 ,pp. : 207-210

Adis International

Access to resources Recommend Favorite

Long-acting injectable risperidone extends time to relapse

By  

Inpharma, Vol. 1, Iss. 1638, 2008-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Switch from atypicals to long-acting risperidone improves symptoms in schizophrenia

By  

Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite